Cengild Medical Berhad Announces Appointment of John Lian Yoon Ahn as Principal Officer - Marketscreener.com
0243 Stock | 0.28 0.01 3.45% |
About 61% of Cengild Medical's investor base is looking to short. The analysis of current outlook of investing in Cengild Medical Berhad suggests that many traders are alarmed regarding Cengild Medical's prospects. Cengild Medical's investing sentiment shows overall attitude of investors towards Cengild Medical Berhad.
Cengild Medical stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Cengild daily returns and investor perception about the current price of Cengild Medical Berhad as well as its diversification or hedging effects on your existing portfolios.
Cengild |
Cengild Medical Berhad Announces Appointment of John Lian Yoon Ahn as Principal Officer Marketscreener.com
Read at news.google.com
Cengild Medical Berhad Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cengild Medical stock to make a market-neutral strategy. Peer analysis of Cengild Medical could also be used in its relative valuation, which is a method of valuing Cengild Medical by comparing valuation metrics with similar companies.
Peers
Cengild Medical Related Equities
7803 | Rubberex M | 5.56 | ||||
6971 | Kobay Tech | 5.30 | ||||
7232 | Resintech Bhd | 4.35 | ||||
7022 | Globetronics Tech | 3.51 | ||||
7148 | Duopharma Biotech | 0.80 | ||||
2453 | Kluang Rubber | 0.35 | ||||
5100 | BP Plastics | 0.83 | ||||
0190 | Eversafe Rubber | 6.25 |